{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:28:19Z","timestamp":1761017299661,"version":"3.37.3"},"reference-count":28,"publisher":"American Diabetes Association","issue":"4","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.2337\/dci19-0076","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:15:46Z","timestamp":1584749746000},"page":"695-697","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":4,"title":["Rethinking Neuropathy in Type 1 Diabetes: Had We Lost Sight of What Matters Most?"],"prefix":"10.2337","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-0046","authenticated-orcid":false,"given":"Bruce A.","family":"Perkins","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of Toronto, and Lunenfeld-Tanenbaum Research Institute Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"2022031223484767100_B1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031223484767100_B2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1938640017694722","article-title":"Patients with diabetic foot disease fear major lower-extremity amputation more than death","volume":"11","author":"Wukich","year":"2018","journal-title":"Foot Ankle Spec"},{"key":"2022031223484767100_B3","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"2022031223484767100_B4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc18-1380","article-title":"Resurgence of diabetes-related nontraumatic lower-extremity amputation in the young and middle-aged adult U.S. population","volume":"42","author":"Geiss","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031223484767100_B5","doi-asserted-by":"crossref","first-page":"E955","DOI":"10.1503\/cmaj.190134","article-title":"Population-based secular trends in lower-extremity amputation for diabetes and peripheral artery disease","volume":"191","author":"Hussain","year":"2019","journal-title":"CMAJ"},{"key":"2022031223484767100_B6","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1016\/j.jcjd.2017.10.028","article-title":"Neuropathy","volume":"42","author":"Diabetes Canada Clinical Practice Guidelines Expert Committee","year":"2018","journal-title":"Can J Diabetes"},{"key":"2022031223484767100_B7","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1016\/j.jcjd.2017.10.020","article-title":"Foot Care","volume":"42","author":"Diabetes Canada Clinical Practice Guidelines Expert Committee","year":"2018","journal-title":"Can J Diabetes"},{"key":"2022031223484767100_B8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/dme.12450","article-title":"The Ipswich Touch Test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration","volume":"31","author":"Sharma","year":"2014","journal-title":"Diabet Med"},{"key":"2022031223484767100_B9","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2337\/dc08-9021","article-title":"Comprehensive foot examination and risk assessment: a report of the task force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists","volume":"31","author":"Boulton","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031223484767100_B10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","article-title":"Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications","volume":"29","author":"Herman","year":"2012","journal-title":"Diabet Med"},{"key":"2022031223484767100_B11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2337\/dc19-1583","article-title":"The contemporary prevalence of diabetic neuropathy in type 1 diabetes: findings from the T1D Exchange","volume":"43","author":"Mizokami-Stout","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031223484767100_B12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc19-1582","article-title":"Diabetic neuropathy is a substantial burden in people with type 1 diabetes and is strongly associated with socioeconomic disadvantage: a population-representative study from Scotland","volume":"43","author":"Jeyam","year":"2020","journal-title":"Diabetes Care"},{"key":"2022031223484767100_B13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N Engl J Med"},{"key":"2022031223484767100_B14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/dc13-2114","article-title":"Neuropathy and related findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Martin","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031223484767100_B15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/XCE.0000000000000164","article-title":"Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburgh Epidemiology of Diabetes Complications study","volume":"8","author":"Costacou","year":"2019","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"2022031223484767100_B16","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2337\/dc16-0102","article-title":"Commonly measured clinical variables are not associated with burden of complications in long-standing type 1 diabetes: results from the Canadian Study of Longevity in Diabetes","volume":"39","author":"Weisman","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031223484767100_B17","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s00125-017-4439-4","article-title":"Lower corneal nerve fibre length identifies diabetic neuropathy in older adults with diabetes: results from the Canadian Study of Longevity in Type 1 Diabetes","volume":"60","author":"Scarr","year":"2017","journal-title":"Diabetologia"},{"key":"2022031223484767100_B18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","article-title":"Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"key":"2022031223484767100_B19","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031223484767100_B20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-5491.2009.02667.x","article-title":"Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy","volume":"26","author":"Bril","year":"2009","journal-title":"Diabet Med"},{"key":"2022031223484767100_B21","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2337\/diacare.25.11.2048","article-title":"Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy","volume":"25","author":"Bril","year":"2002","journal-title":"Diabetes Care"},{"key":"2022031223484767100_B22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jdiacomp.2015.01.011","article-title":"Clinical neuropathy scales in neuropathy associated with impaired glucose tolerance","volume":"29","author":"Zilliox","year":"2015","journal-title":"J Diabetes Complications"},{"key":"2022031223484767100_B23","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S2213-8587(19)30081-6","article-title":"Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention","volume":"7","author":"Selvarajah","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031223484767100_B24","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s00125-018-4653-8","article-title":"Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study","volume":"61","author":"Perkins","year":"2018","journal-title":"Diabetologia"},{"key":"2022031223484767100_B25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1210\/er.2018-00107","article-title":"Emerging biomarkers, tools, and treatments for diabetic polyneuropathy","volume":"40","author":"B\u00f6nhof","year":"2019","journal-title":"Endocr Rev"},{"key":"2022031223484767100_B26","doi-asserted-by":"crossref","first-page":"e0177210","DOI":"10.1371\/journal.pone.0177210","article-title":"Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: a systematic review","volume":"12","author":"Scott","year":"2017","journal-title":"PLoS One"},{"key":"2022031223484767100_B27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/bs.irn.2016.03.008","article-title":"Wherefore art thou, o treatment for diabetic neuropathy?","volume":"127","author":"Malik","year":"2016","journal-title":"Int Rev Neurobiol"},{"author":"Callaghan","key":"2022031223484767100_B28"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/4\/695\/532297\/dci190076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/4\/695\/532297\/dci190076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:43:27Z","timestamp":1647143007000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/4\/695\/35750\/Rethinking-Neuropathy-in-Type-1-Diabetes-Had-We"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,3,12]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci19-0076","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"type":"print","value":"0149-5992"},{"type":"electronic","value":"1935-5548"}],"subject":[],"published":{"date-parts":[[2020,3,12]]}}}